Kivitz, Alan J <br/><br/>
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.  [electronic resource] 

 -  Pain  07 2013 
 - 1009-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6623 
<br/><br/><label>Standard No.: </label>10.1016/j.pain.2013.03.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Analgesics--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Chronic Pain--drug therapy<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Humans<br/>Low Back Pain--drug therapy<br/>Male<br/>Middle Aged<br/>Naproxen--therapeutic use<br/>Pain Measurement--drug effects<br/>Placebo Effect<br/>Prevalence<br/>Risk Factors<br/>Treatment Outcome<br/>United States--epidemiology<br/>Young Adult